{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:38:54Z","timestamp":1791689934739,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011478","name":"Foshan Municipal Science and Technology Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.pdpdt.2024.104067","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T07:37:20Z","timestamp":1711438640000},"page":"104067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization"],"prefix":"10.1016","volume":"46","author":[{"given":"Xiao-Fang","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Jin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pdpdt.2024.104067_bib0001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"issue":"7","key":"10.1016\/j.pdpdt.2024.104067_bib0002","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","article-title":"Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis","volume":"117","author":"Bachmann","year":"2010","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104067_bib0003","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2353\/ajpath.2007.070172","article-title":"Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis","volume":"171","author":"Nakao","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.pdpdt.2024.104067_bib0004","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00417-007-0587-4","article-title":"Subconjunctival bevacizumab for corneal neovascularization","volume":"245","author":"Erdurmus","year":"2007","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.pdpdt.2024.104067_bib0005","first-page":"595","article-title":"Laser photocoagulation for corneal stromal vascularization","volume":"90","author":"Nirankari","year":"1992","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"8","key":"10.1016\/j.pdpdt.2024.104067_bib0006","first-page":"2148","article-title":"Fine needle diathermy occlusion of corneal vessels","volume":"41","author":"Pillai","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104067_bib0007","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/02713680600559564","article-title":"Experimental inhibition of corneal neovascularization by photodynamic therapy with verteporfin","volume":"31","author":"Yoon","year":"2006","journal-title":"Curr. Eye Res."},{"issue":"7","key":"10.1016\/j.pdpdt.2024.104067_bib0008","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bjo.2008.144410","article-title":"Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study","volume":"93","author":"Schmid-Kubista","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104067_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00417-008-0952-y","article-title":"A systematic review on the effect of bevacizumab in exudative age-related macular degeneration","volume":"247","author":"Schouten","year":"2009","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"issue":"10","key":"10.1016\/j.pdpdt.2024.104067_bib0010","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104067_bib0011","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/01.ico.0000611440.32234.8f","article-title":"Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis","volume":"27","author":"Carrasco","year":"2008","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104067_bib0012","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICO.0b013e3181e458c5","article-title":"Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition","volume":"30","author":"Chu","year":"2011","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104067_bib0013","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1755-3768.2008.01399.x","article-title":"Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization","volume":"87","author":"You","year":"2009","journal-title":"Acta Ophthalmol."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104067_bib0014","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/ICO.0b013e318158f6ad","article-title":"Topical bevacizumab and ocular surface neovascularization in patients with stevens-johnson syndrome","volume":"27","author":"Uy","year":"2008","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104067_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713680701799101","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization in recurrent pterygium","volume":"33","author":"Bahar","year":"2008","journal-title":"Curr. Eye Res."},{"issue":"11","key":"10.1016\/j.pdpdt.2024.104067_bib0016","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.jcrs.2007.07.012","article-title":"Subconjunctival bevacizumab for vascularized rejected corneal grafts","volume":"33","author":"Awadein","year":"2007","journal-title":"J. Cataract. Refract. Surg."},{"issue":"69","key":"10.1016\/j.pdpdt.2024.104067_bib0017","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001699","article-title":"Photodynamic ablation of lymphatic vessels and intralymphatic cancer cells prevents metastasis","volume":"3","author":"Tammela","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.pdpdt.2024.104067_bib0018","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","volume":"117","year":"1999","journal-title":"Arch. Ophthalmol."},{"issue":"9","key":"10.1016\/j.pdpdt.2024.104067_bib0019","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1097\/OPX.0000000000000349","article-title":"Photodynamic therapy for choroidal hemangioma unresponsive to ranibizumab","volume":"91","author":"Chan","year":"2014","journal-title":"Optom. Vis. Sci.: Off. Public. Am. Acad. Optom."},{"issue":"2","key":"10.1016\/j.pdpdt.2024.104067_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/IAE.0000000000001138","article-title":"Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy","volume":"37","author":"Cheng","year":"2017","journal-title":"Retina"},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104067_bib0021","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/bjo.2003.035071","article-title":"Photodynamic therapy for corneal neovascularisation and lipid degeneration","volume":"88","author":"Brooks","year":"2004","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104067_bib0022","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ajo.2007.05.028","article-title":"Photodynamic therapy with verteporfin for corneal neovascularization","volume":"144","author":"Yoon","year":"2007","journal-title":"Am. J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.pdpdt.2024.104067_bib0023","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1167\/iovs.02-0572","article-title":"Photodynamic therapy with verteporfin in a rabbit model of corneal neovascularization","volume":"44","author":"Holzer","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104067_bib0024","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajo.2006.01.085","article-title":"Expression of VEGF and PEDF in choroidal neovascular membranes following verteporfin photodynamic therapy","volume":"142","author":"Tatar","year":"2006","journal-title":"Am. J. Ophthalmol."},{"issue":"12","key":"10.1016\/j.pdpdt.2024.104067_bib0025","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/ICO.0000000000001016","article-title":"Effects of combined photodynamic therapy and topical bevacizumab treatment on corneal neovascularization in rabbits","volume":"35","author":"Kim","year":"2016","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104067_bib0026","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/ICO.0b013e3181dc81a0","article-title":"Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization","volume":"30","author":"You","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.pdpdt.2024.104067_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1210765","article-title":"Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns","volume":"10","author":"Peng","year":"2023","journal-title":"Front. Med."},{"issue":"4","key":"10.1016\/j.pdpdt.2024.104067_bib0028","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.sjopt.2010.05.002","article-title":"Regression of aggressive corneal vascularization after photodynamic therapy, subconjunctival Avastin injections and topical cyclosporin-A 1% drops: A case report","volume":"24","author":"Kirat","year":"2010","journal-title":"Saudi J. Ophthalmol.: Off. J. Saudi Ophthalmol. Soc."},{"issue":"11","key":"10.1016\/j.pdpdt.2024.104067_bib0029","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/ICO.0b013e31821c9b44","article-title":"A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: preliminary results","volume":"30","author":"Enkvetchakul","year":"2011","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.pdpdt.2024.104067_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ICO.0b013e3182151e0e","article-title":"Randomized controlled trial of subconjunctival bevacizumab injection in impending recurrent pterygium: a pilot study","volume":"31","author":"Lekhanont","year":"2012","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.pdpdt.2024.104067_bib0031","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bjo.2011.204701","article-title":"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable","volume":"96","author":"Cursiefen","year":"2012","journal-title":"Br. J. Ophthalmol."},{"issue":"10","key":"10.1016\/j.pdpdt.2024.104067_bib0032","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/ICO.0b013e31820cd3f4","article-title":"Compensatory growth factor and cytokine response in tears after subconjunctival bevacizumab injection","volume":"30","author":"Jeong","year":"2011","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.pdpdt.2024.104067_bib0033","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"issue":"6","key":"10.1016\/j.pdpdt.2024.104067_bib0034","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","article-title":"The effect of topical bevacizumab on corneal neovascularization","volume":"115","author":"Kim","year":"2008","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.pdpdt.2024.104067_bib0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/ICO.0b013e31818b8be0","article-title":"Evaluation of cytotoxic effects of bevacizumab on human corneal cells","volume":"28","author":"Chalam","year":"2009","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.pdpdt.2024.104067_bib0036","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/ICO.0b013e3180de1d0a","article-title":"Safety profile of bevacizumab on cultured human corneal cells","volume":"26","author":"Yoeruek","year":"2007","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.pdpdt.2024.104067_bib0037","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1590\/S1807-59322011000800023","article-title":"The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model","volume":"66","author":"Mello","year":"2011","journal-title":"Clinics"},{"issue":"10","key":"10.1016\/j.pdpdt.2024.104067_bib0038","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1167\/iovs.08-2805","article-title":"Bevacizumab application delays epithelial healing in rabbit cornea","volume":"50","author":"Kim","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.pdpdt.2024.104067_bib0039","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bjophthalmol-2011-300856","article-title":"Evaluation of corneal neovascularisation","volume":"95","author":"Faraj","year":"2011","journal-title":"Br. J. Ophthalmol."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100024001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100024001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T03:21:36Z","timestamp":1716952896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100024001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":39,"alternative-id":["S1572100024001066"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104067","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2024.104067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104067"}}